Introduction
Early diagnosis of lentigo maligna (LM) represents one of the most challenging tasks in dermato-oncology. This is because pigmented actinic keratosis (pAK), solar lentigo (SL), seborrheic keratosis (SK), and lichen planus-like keratosis (LPLK) share several phenotypic features with melanoma in situ both macroscopically and on dermoscopic examination [1] . Dermoscopy remains the primary diagnostic method for differentiating among these tumors; however, currently used algorithms demonstrate a low accuracy for LM [2] . For instance, gray structures in a flat pigmented facial lesion can be a sign of LM but can be found also in pAK and LPLK [1, 2] . Rhomboidal structures can be seen in both LM and pAK whereas a pseudonetwork can be additionally present in many SL and SK [1] .
Total excision provides a definite diagnosis but is associated with the risk of undesirable cosmetic result.
Recently, a new algorithm was introduced with high specificity and nearly 70% sensitivity for LM. Rather than aiming to the recognition of melanoma-specific criteria, it focuses on the dermoscopic presence or absence of 7 features of nonmelanoma tumors: scales, white follicles, erythema, reticular or curved lines, structureless brown color, sharp demarcation, and classic criteria of SK such as milia-like cysts [2] . If any of these 7 features is clearly recognized and widely distributed on the surface of the lesion, the diagnosis of LM is excluded and biopsy is not necessary. In the absence of these features, the lesion is considered suspicious even without displaying any melanoma-specific criterion.
Case Presentation
We report a case of a 50-year-old woman who visited our Following the aforementioned novel algorithm, since none of the 7 nonmelanoma features was clearly present, we could not exclude the diagnosis of facial melanoma and performed an excisional biopsy. Indeed, the histopathological examination revealed melanoma in situ and the patient underwent wide excision of the scar with safety margins (Figure 3) . In addition, the patient received adjuvant treatment with imiquimod 5% cream, consisting of 5 daily applications per week for 6 weeks [5] .
Conclusions
The recognition of such a small and dermoscopically inconspicuous melanoma would be impossible by any strategy focusing on melanoma-specific structures. Early dermoscopic diagnosis of facial melanoma should rather be a diagnosis of exclusion, based on the absence of nonmelanoma features. 
